Good news_老虎社区_美港股上老虎

HKpoh
2021-11-30

Good news

摩根大通称变异毒株Omicron不会阻止全球股市上涨

摩根大通策略师表示，Omicron不会令全球股市涨势脱轨，加入了市场中谨慎乐观的阵营。

摩根大通称变异毒株Omicron不会阻止全球股市上涨

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":609877536,"tweetId":"609877536","gmtCreate":1638272691551,"gmtModify":1638272691739,"author":{"id":4090651426001740,"idStr":"4090651426001740","authorId":4090651426001740,"authorIdStr":"4090651426001740","name":"HKpoh","avatar":"https://static.tigerbbs.com/c7e76b0a89262ef58fedef12ced230ca","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":33,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Good news&nbsp;</p></body></html>","htmlText":"<html><head></head><body><p>Good news&nbsp;</p></body></html>","text":"Good news","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/609877536","repostId":2187381581,"repostType":4,"repost":{"id":"2187381581","kind":"news","pubTimestamp":1638268260,"share":"https://www.laohu8.com/m/news/2187381581?lang=zh_CN&edition=full","pubTime":"2021-11-30 18:31","market":"us","language":"zh","title":"摩根大通称变异毒株Omicron不会阻止全球股市上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2187381581","media":"市场资讯","summary":"摩根大通策略师表示，Omicron不会令全球股市涨势脱轨，加入了市场中谨慎乐观的阵营。","content":"<p><a href=\"https://laohu8.com/S/JPM\">摩根大通</a>策略师表示，Omicron不会令全球股市涨势脱轨，加入了市场中谨慎乐观的阵营。</p>\n<p><img src=\"https://static.tigerbbs.com/141509c30ce97af69ff6c6c061175b4c\" tg-width=\"550\" tg-height=\"337\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Dubravko Lakos-Bujas、Mislav Matejka等策略师在一份报告中写道，omicron出现等“偶发性挫折”，应该放在“自然免疫和疫苗接种后免疫增加、死亡率显著降低、特效药诞生的大背景下”来看。“我们预计，2022年疫后正常化进程将在全球继续推进，”他们指出。</p>\n<p>亚欧股市和美股期货周二纷纷下跌，因莫德纳首席执行官Stephane Bancel表示，现有疫苗可能难以对付新型变异毒株omicron。目前科学家仍在研究这种变异株会引发什么样的症状，而包括莫德纳、<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>和<a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a>在内的制药公司已经在着手研发新的疫苗。</p>\n<p>“我们仍旧预计市场有上行空间，尽管更为温和，因为企业盈利增长好于预期，供应链冲击缓解，新兴市场背景改善，消费者支出习惯正在恢复正常，”摩根大通周二表示。该行预计标普500指数到2022年底将上涨约9%，至5050点。这些策略师们认为，央行政策转鹰是关键风险。</p>","source":"sina","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>摩根大通称变异毒株Omicron不会阻止全球股市上涨</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n摩根大通称变异毒株Omicron不会阻止全球股市上涨\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 18:31 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/usstock/c/2021-11-30/doc-ikyamrmy6013858.shtml><strong>市场资讯</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>摩根大通策略师表示，Omicron不会令全球股市涨势脱轨，加入了市场中谨慎乐观的阵营。\n\nDubravko Lakos-Bujas、Mislav Matejka等策略师在一份报告中写道，omicron出现等“偶发性挫折”，应该放在“自然免疫和疫苗接种后免疫增加、死亡率显著降低、特效药诞生的大背景下”来看。“我们预计，2022年疫后正常化进程将在全球继续推进，”他们指出。\n亚欧股市和美股期货周二纷纷...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/usstock/c/2021-11-30/doc-ikyamrmy6013858.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/55eb327f580527889cf30bafa92692ae","relate_stocks":{"BK4566":"资本集团","JPM":"摩根大通","BK4550":"红杉资本持仓","BK4534":"瑞士信贷持仓","BK4504":"桥水持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4207":"综合性银行"},"source_url":"https://finance.sina.com.cn/stock/usstock/c/2021-11-30/doc-ikyamrmy6013858.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","article_id":"2187381581","content_text":"摩根大通策略师表示，Omicron不会令全球股市涨势脱轨，加入了市场中谨慎乐观的阵营。\n\nDubravko Lakos-Bujas、Mislav Matejka等策略师在一份报告中写道，omicron出现等“偶发性挫折”，应该放在“自然免疫和疫苗接种后免疫增加、死亡率显著降低、特效药诞生的大背景下”来看。“我们预计，2022年疫后正常化进程将在全球继续推进，”他们指出。\n亚欧股市和美股期货周二纷纷下跌，因莫德纳首席执行官Stephane Bancel表示，现有疫苗可能难以对付新型变异毒株omicron。目前科学家仍在研究这种变异株会引发什么样的症状，而包括莫德纳、辉瑞和BioNTech SE在内的制药公司已经在着手研发新的疫苗。\n“我们仍旧预计市场有上行空间，尽管更为温和，因为企业盈利增长好于预期，供应链冲击缓解，新兴市场背景改善，消费者支出习惯正在恢复正常，”摩根大通周二表示。该行预计标普500指数到2022年底将上涨约9%，至5050点。这些策略师们认为，央行政策转鹰是关键风险。","news_type":1,"symbols_score_info":{"JPM":0.9}},"isVote":1,"tweetType":1,"viewCount":1002,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":8,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}